Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |